INFLAMMASOME THERAPEUTICS
Inflammasome Therapeutics Inc found to develop therapies for prevalent, degenerative diseases.
INFLAMMASOME THERAPEUTICS
Industry:
Biotechnology Health Care
Address:
Newton, Massachusetts, United States
Country:
United States
Website Url:
http://www.inflam.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Apache
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Galenea
Galenea is engaged in developing therapeutics for central nervous system diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.inflam.com Semrush global rank: 5.74 M Semrush visits lastest month: 1.46 K
- Host name: lamp130.cloudaccess.net
- IP address: 104.37.86.23
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Inflammasome Therapeutics"
Inflammasome Therapeutics - Home
Inflammasome Therapeutics is a science-based company founded to develop therapies for prevalent, degenerative diseases such as Alzheimer’s disease, multiple sclerosis, macular …See details»
Inflammasome Therapeutics - Crunchbase Company …
Contact Email [email protected] Phone Number 617-331-1071 Inflammasome Therapeutics develops therapies for prevalent, degenerative diseases like Alzheimer’s disease and Parkinson's disease.See details»
Inflammasome Therapeutics - About
Inflammasome Therapeutics - Leadership Team
Paul Ashton, Ph.D. Co-Founder, CEO, and Chairman of the Board Jayakrishna Ambati, M.D. Co-Founder and Board Member Balamurali Ambati, M.D., Ph.D., M.B.A. Board Member ...See details»
Inflammasome Therapeutics Company Profile | Management and …
Inflammasome Therapeutics (www.inflam.com) was founded by Jayakrishna Ambati, M.D. and Paul Ashton, Ph.D., in 2016 to develop therapies for prevalent, degenerative diseases and to …See details»
Inflammasome Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Explore Inflammasome Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 10 news, Disease Domain:Endocrinology and ...See details»
Inflammasome Therapeutics - PitchBook
Inflammasome Therapeutics General Information Description. Developer of therapies designed to focus on prevalent, degenerative diseases such as Alzheimer's and multiple sclerosis.See details»
Inflammasome Therapeutics - Overview, News & Similar
Nov 12, 2023 Inflammasome Therapeutics to Enter Clinic with Treatment for Dry AMD NEWTON, Mass.--(BUSINESS WIRE)-- #NRTIs--Inflammasome Therapeutics …See details»
Inflammasome Therapeutics - Devex
Inflammasome Therapeutics is a science-based company founded to develop therapies for prevalent, degenerative diseases such as Alzheimer’s disease, multiple sclerosis, macular …See details»
Inflammasome Therapeutics Inc Overview - Salary.com
Discover essential details about Inflammasome Therapeutics Inc, including address, contact, and journey of our company's evolution.See details»
Infra Pharmaceuticals
INFLAM APS Aceclofenac - 100 mg + Paracetamol - 325 mg + Serratiopeptidase - 10 mg Tablet Download Brochure. ... Finance and Law backgrounds. With the Goodwill of 20 + years now …See details»
Kamuvudine-8 - Drug Targets, Indications, Patents - Synapse
Active Organization. Inflammasome Therapeutics, Inc. Startup University of Kentucky. Inactive Organization-Drug Highest Phase Phase 1. First Approval Date- ... Inflammasome …See details»
Inflammasome Therapeutics to Enter linic with Treatment for Dry …
Inflammasome Therapeutics (https://www.inflam.com) was founded by Jayakrishna Ambati, M.D., and Paul Ashton, Ph.D., in 2016 to develop therapies for prevalent, degenerative diseases …See details»
InflAIM
This is the website of the development research project on the Inflammatory drivers of shared long-term disease trajectories: an AI investigation of multimorbidity (inflAIM) funded by the NIHR.See details»
Inflam-X LPT Fact Sheet - EVEXIAS Health Solutions
What's more, Inflam-X LPT is a liposomal chewable tablet whose innovative delivery. technology uses tiny, manmade, lipid-based cells to deliver nutraceuticals to targeted. sites in the body, …See details»
Inflam | 400 mg | Tablet | Synovia Pharma PLC. - MedEx
Inflam topical gel contains Inflam and belongs to a group of medicines called non-steroid anti-inflammatory drugs (NSAIDs). These medicines reduce pain and inflammation and bring down …See details»
Boehringer Ingelheim Partners with Inflammasome Therapeutics …
Inflammasome Therapeutics (www.inflam.com) is a science based company founded to develop therapies for prevalent, degenerative diseases such as Alzheimer’s disease, multiple sclerosis …See details»
Inflam - Nutritional Frontiers
Inflam Available in 90 or 180 Count Vegetarian Capsules The ingredients in Inflam II can reduce the pain, swelling, & inflammation found in arthritis. This formula was designed to help …See details»
Inflammasome Therapeutics - News
Inflammasome Therapeutics Completes Enrollment in Study for First Oral Dual Inflammasome Inhibitor for Ophthalmic and Neuroinflammatory Diseases September 2024 Inflammasome …See details»
Inflammasome Therapeutics - Macular Degeneration
Inflammasome & Dry Age Related Macular Degeneration. Dry-Age Related Macular Degeneration is the only major ophthalmic disease with no approved treatment and is one of most common …See details»